• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 129-143 of 562 results

1007 Exhibit: Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Protein...

Document IPR2017-01103, No. 1007-6 Exhibit - Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis, Arch Ophalmol vol 100, 484 87 March 1982 (P...

cite Cite Document
Analyze

2019 Exhibit: Exhibit 2019

Document IPR2017-01103, No. 2019-46 Exhibit - Exhibit 2019 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007...

Document IPR2017-01103, No. 1018-17 Exhibit - Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007, a Cremophor free, protein stabilized, nanoparticle formulation of paclitaxel, Clin Can...

cite Cite Document
Analyze

2016 Exhibit: Exhibit 2016

Document IPR2017-01103, No. 2016-43 Exhibit - Exhibit 2016 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

2059 Exhibit: Exhibit 2059

Document IPR2017-01103, No. 2059-83 Exhibit - Exhibit 2059 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

2008 Exhibit: Exhibit 2008

Document IPR2017-01103, No. 2008-35 Exhibit - Exhibit 2008 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

1026 Exhibit: Ex 1026 Desai et al, US Patent No 5,916,596 issued Jun 29, 1999

Document IPR2017-01103, No. 1026-25 Exhibit - Ex 1026 Desai et al, US Patent No 5,916,596 issued Jun 29, 1999 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

2043 Exhibit: Exhibit 2043

Document IPR2017-01103, No. 2043-69 Exhibit - Exhibit 2043 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

2009 Exhibit: Exhibit 2009

Document IPR2017-01103, No. 2009-36 Exhibit - Exhibit 2009 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

1002 Exhibit: Ex 1002 Declaration Of Cory J Berkland, PhD

Document IPR2017-01103, No. 1002-27 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

2064 Exhibit: Exhibit 2064 Declaration of Andrew S Chalson IPR2014 01103

Document IPR2017-01103, No. 2064-92 Exhibit - Exhibit 2064 Declaration of Andrew S Chalson IPR2014 01103 (P.T.A.B. Nov. 8, 2017)

cite Cite Document
Analyze

2005 Exhibit: Exhibit 2005

Document IPR2017-01103, No. 2005-32 Exhibit - Exhibit 2005 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze

1021 Exhibit: Ex 1021 US Application No 11553,339, Final Office Action mailed Dec...

Document IPR2017-01103, No. 1021-20 Exhibit - Ex 1021 US Application No 11553,339, Final Office Action mailed Dec 31, 2009 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1025 Exhibit: Ex 2025 FDA, Approved Drug Products with Therapeutic Equivalence...

Document IPR2017-01103, No. 1025-24 Exhibit - Ex 2025 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

2012 Exhibit: Exhibit 2012

Document IPR2017-01103, No. 2012-39 Exhibit - Exhibit 2012 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 9 10 11 12 13 ... >>